Karen Hartley

Lead clinical pharmacist – paediatric rheumatology at Newcastle-upon-Tyne Hospitals NHS Foundation Trust.

Juvenile idiopathic arthritis: biologic disease modifying anti-rheumatic drugs

Biologic disease modifying anti-rheumatic drugs have greatly changed the treatment and outcomes of juvenile idiopathic arthritis; there are many considerations for their use that pharmacists should be aware of.…

Juvenile idiopathic arthritis: recognition, diagnosis and conventional pharmacological management

Juvenile idiopathic arthritis is the most common chronic childhood rheumatic disease. Pharmacists are a vital part of the multidisciplinary team and should be aware of the considerations for pharmacological management.…